References
- National Asthma Education and Prevention Program. Expert Panel Report: guidelines for the diagnosis and management of asthma. Update on selected topics–2002. J Allergy Clin Immunol 2002; 110: S141–S219
- Global strategy for asthma management and prevention. Global Initiative for Asthma. 2006; S219, Available at, www.ginasthma.org Revised, Accessed November 2006
- Stoloff S W, Stempel D A, Meyer J, Stanford R H, Carranza J R. Improved refill persistency with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies. J Allergy Clin Immunol 2004; 113: 245–251
- Bender B, Milgrom H, Rand C. Nonadherence in asthmatic patients: is there a solution to the problem?. Ann Allergy Asthma Immunol 1997; 79: 177–186
- Noonan M, Rosenwasser L J, Martin P, O'Brien C D, O'Dowd L. Efficacy and safety of budesonide and formoterol in one pressurized metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial. Drugs 2006; 66: 2235–2254
- Pauwels R A, Löfdahl C G, Postma D S, Tattersfield A E, O'Byrne P, Barnes P J, Ullman A, for the Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. Effect of inhaled formoterol and budesonide on exacerbations of asthma. N Engl J Med 1997; 337: 1405–1411
- Corren J, Korenblat P E, Miller C J, O'Brien C D, Mezzanotte W S. Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and formoterol alone in adolescents and adults with asthma. Clin Ther 2007; 29: 823–843
- Ankerst J, Lötvall J, Cassidy S, Byrne N. Comparison of the bronchodilating effects of formoterol and albuterol delivered by hydrofluoroalkane pressurized metered-dose inhaler. Treat Respir Med 2005; 4: 123–127
- Seberová E, Andersson A. Oxis® (formoterol given by Turbuhaler®) showed as rapid an onset of action as salbutamol given by a pMDI. Respir Med 2000; 94: 607–611
- Grembiale R D, Pelaia G, Naty S, Vatrella A, Tranfa C ME, Marsico S A. Comparison of the bronchodilating effects of inhaled formoterol, salmeterol and salbutamol in asthmatic patients. Pulm Pharmacol Ther 2002; 15: 463–466
- Palmqvist M, Arvidsson P, Beckman O, Peterson S, Lötvall J. Onset of bronchodilation of budesonide/formoterol vs. salmeterol/fluticasone in single inhalers. Pulm Pharmacol Ther 2001; 14: 29–34
- van d er, Woude H J, Boorsma M, Bergqvist P BF, Winter T H, Aalbers R. Budesonide/formoterol in a single inhaler rapidly relieves methacholine-induced moderate-to-severe bronchoconstriction. Pulm Pharmacol Ther 2004; 17: 89–95
- American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Resp Dis. 1987; 136: 225–244
- Bender B G, Bender S E. Patient-identified barriers to asthma treatment adherence: responses to interviews, focus groups, and questionnaires. Immunol Allergy Clin N Am 2005; 25: 107–130
- Lai C KW, de Guia T S, Kim Y-Y, al et. on behalf of the Asthma Insights and Reality in Asia-Pacific Steering Committee. Asthma, rhinitis, other respiratory diseases. Asthma control in the Asia-Pacific region: the Asthma Insights and Reality in Asia-Pacific Study. J Allergy Clin Immunol 2003; 111: 263–268
- Cockcroft D W, Jokic R, Marciniuk D D, Fitzpatrick M F. The current dilemma with spirometric inclusion criteria for asthma drug trials. Ann Allergy Asthma Immunol 1997; 79: 226–228
- Politiek M J, Boorsma M, Aalbers R. Comparison of formoterol, salbutamol and salmeterol in methacholine-induced severe bronchoconstriction. Eur Respir J 1999; 13: 988–992
- van Noord J A, Smeets J J, Raaijmakers J AM, Bommer A M, Maesen F PV. Salmeterol versus formoterol in patients with moderately severe asthma: onset and duration of action. Eur Respir J 1996; 9: 1684–1688
- Balanag V M, Yunus F, Yang P-C, Jorup C. Efficacy and safety of budesonide/formoterol compared with salbutamol in the treatment of acute asthma. Pulm Pharmacol Ther 2006; 19: 139–147